Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CASP3 | P42574 | 2/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.35 |
| ▸ | MLNR | O43193 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4206573 | 0.77 | PDK2 (0.42) | ALDH1A1CASP3SENP8SENP7SENP6 | |
| SCHEMBL13278527 | 0.73 | ALDH1A1 (0.50) | ALDH1A1CASP3SENP8SENP7SENP6 | |
| SCHEMBL6504078 | 0.72 | GABBR2 (0.36) | — | |
| SCHEMBL12263949 | 0.70 | LPL (0.33) | — | |
| SCHEMBL28627082 | 0.68 | MEN1 (0.41) | ALDH1A1CASP3SENP8SENP7SENP6 | |
| SCHEMBL26489506 | 0.68 | NPC1 (0.36) | ALDH1A1CASP3SENP8SENP7SENP6 | |
| SCHEMBL23511916 | 0.68 | TDP1 (0.42) | MLNRNR1I2CHRM2ADRB1HTR1A | |
| SCHEMBL15853142 | 0.68 | PDK2 (0.36) | PGR | |
| SCHEMBL22197696 | 0.67 | NPC1 (0.30) | ALDH1A1CASP3SENP8SENP7SENP6 | |
| SCHEMBL2524003 | 0.67 | NPC1 (0.35) | ALDH1A1CASP3SENP8SENP7SENP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8072137-B2 | Fused heterocyclic compound and organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2011-12-06 | — | — | US | disclosed |
| US-20090121625-A1 | FUSED HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-05-14 | — | — | US | disclosed |
| WO-2008016166-A1 | FUSED HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090121625-A1 | FUSED HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | TYR, CRY1, LAGE3 | ALDH1A1 145/4885CASP3 2906/4885SENP8 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.